nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Ethinamate—CA2—osteoporosis	0.0231	1	CrCbGaD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—PARK7—osteoporosis	0.0104	0.103	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.00939	0.0933	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—osteoporosis	0.00634	0.063	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.00475	0.0472	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.00374	0.0372	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—osteoporosis	0.00353	0.0351	CbGpPWpGaD
Gabapentin—CACNA2D2—Adrenaline,noradrenaline inhibits insulin secretion—ADCY5—osteoporosis	0.00339	0.0337	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—ID4—osteoporosis	0.00333	0.0331	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—RAP1A—osteoporosis	0.00286	0.0284	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—RAP1A—osteoporosis	0.00225	0.0224	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSMA2—osteoporosis	0.00184	0.0183	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSMA5—osteoporosis	0.00184	0.0183	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—ADCY5—osteoporosis	0.00151	0.015	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.00134	0.0134	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—ADCY5—osteoporosis	0.00119	0.0118	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00106	0.0106	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.00104	0.0103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CALCR—osteoporosis	0.000975	0.00969	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTH1R—osteoporosis	0.000975	0.00969	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PKM—osteoporosis	0.000909	0.00904	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FDPS—osteoporosis	0.000909	0.00904	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPD2—osteoporosis	0.000862	0.00857	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PGLS—osteoporosis	0.000862	0.00857	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR2—osteoporosis	0.000824	0.00819	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—ADCY5—osteoporosis	0.000814	0.00809	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ATIC—osteoporosis	0.000788	0.00784	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PNP—osteoporosis	0.000788	0.00784	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000765	0.0076	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000704	0.00699	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—OXCT1—osteoporosis	0.00067	0.00666	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CA2—osteoporosis	0.00067	0.00666	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000655	0.00652	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MGLL—osteoporosis	0.000653	0.00649	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—IDH2—osteoporosis	0.000555	0.00552	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CALCR—osteoporosis	0.000551	0.00548	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTH1R—osteoporosis	0.000551	0.00548	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PKM—osteoporosis	0.000551	0.00547	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FDPS—osteoporosis	0.000551	0.00547	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—ADCY5—osteoporosis	0.000539	0.00536	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPD2—osteoporosis	0.000522	0.00519	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PGLS—osteoporosis	0.000522	0.00519	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP27A1—osteoporosis	0.000522	0.00519	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTH—osteoporosis	0.000512	0.00509	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ACP5—osteoporosis	0.000508	0.00505	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTH1R—osteoporosis	0.0005	0.00497	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALCR—osteoporosis	0.0005	0.00497	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR2—osteoporosis	0.000499	0.00496	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PNP—osteoporosis	0.000477	0.00475	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ATIC—osteoporosis	0.000477	0.00475	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TPI1—osteoporosis	0.000472	0.00469	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—WNT1—osteoporosis	0.000469	0.00466	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—P4HB—osteoporosis	0.000444	0.00441	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—ADCY5—osteoporosis	0.000439	0.00436	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—MGLL—osteoporosis	0.000438	0.00435	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GAPDH—osteoporosis	0.000436	0.00433	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—osteoporosis	0.000426	0.00423	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—RAP1A—osteoporosis	0.000424	0.00422	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTHLH—osteoporosis	0.000424	0.00422	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—OXCT1—osteoporosis	0.000406	0.00404	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CA2—osteoporosis	0.000406	0.00404	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MGLL—osteoporosis	0.000397	0.00395	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MGLL—osteoporosis	0.000396	0.00393	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CALCA—osteoporosis	0.000374	0.00371	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ENO1—osteoporosis	0.000343	0.00341	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMA5—osteoporosis	0.000338	0.00336	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMA2—osteoporosis	0.000338	0.00336	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—IDH2—osteoporosis	0.000336	0.00334	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOST—osteoporosis	0.000327	0.00325	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—POMC—osteoporosis	0.000323	0.00321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP27A1—osteoporosis	0.000316	0.00314	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ACP5—osteoporosis	0.000308	0.00306	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTH1R—osteoporosis	0.000296	0.00294	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALCR—osteoporosis	0.000296	0.00294	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTH—osteoporosis	0.000289	0.00288	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TPI1—osteoporosis	0.000286	0.00284	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000284	0.000324	CcSEcCtD
Gabapentin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000283	0.000323	CcSEcCtD
Gabapentin—Pruritus—Alendronate—osteoporosis	0.000283	0.000322	CcSEcCtD
Gabapentin—Dyspepsia—Risedronate—osteoporosis	0.000282	0.000322	CcSEcCtD
Gabapentin—Eye disorder—Estradiol—osteoporosis	0.000282	0.000322	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CNR2—osteoporosis	0.000282	0.0028	CbGpPWpGaD
Gabapentin—Tinnitus—Estradiol—osteoporosis	0.000281	0.000321	CcSEcCtD
Gabapentin—Constipation—Ethinyl Estradiol—osteoporosis	0.000281	0.000321	CcSEcCtD
Gabapentin—Confusional state—Zoledronate—osteoporosis	0.000281	0.00032	CcSEcCtD
Gabapentin—Hypersensitivity—Calcitriol—osteoporosis	0.00028	0.00032	CcSEcCtD
Gabapentin—Cardiac disorder—Estradiol—osteoporosis	0.00028	0.00032	CcSEcCtD
Gabapentin—Arthralgia—Conjugated Estrogens—osteoporosis	0.00028	0.000319	CcSEcCtD
Gabapentin—Chest pain—Conjugated Estrogens—osteoporosis	0.00028	0.000319	CcSEcCtD
Gabapentin—Myalgia—Conjugated Estrogens—osteoporosis	0.00028	0.000319	CcSEcCtD
Gabapentin—Asthenia—Ibandronate—osteoporosis	0.000279	0.000318	CcSEcCtD
Gabapentin—Anxiety—Conjugated Estrogens—osteoporosis	0.000279	0.000318	CcSEcCtD
Gabapentin—Nausea—Etidronic acid—osteoporosis	0.000278	0.000318	CcSEcCtD
Gabapentin—Oedema—Zoledronate—osteoporosis	0.000278	0.000318	CcSEcCtD
Gabapentin—Anaphylactic shock—Zoledronate—osteoporosis	0.000278	0.000318	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000278	0.000317	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000278	0.000317	CcSEcCtD
Gabapentin—Diarrhoea—Estropipate—osteoporosis	0.000277	0.000317	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000277	0.000316	CcSEcCtD
Gabapentin—Infection—Zoledronate—osteoporosis	0.000276	0.000315	CcSEcCtD
Gabapentin—Fatigue—Risedronate—osteoporosis	0.000276	0.000315	CcSEcCtD
Gabapentin—Insomnia—Pamidronate—osteoporosis	0.000276	0.000314	CcSEcCtD
Gabapentin—Pruritus—Ibandronate—osteoporosis	0.000275	0.000314	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP19A1—osteoporosis	0.000274	0.00273	CbGpPWpGaD
Gabapentin—Pain—Risedronate—osteoporosis	0.000274	0.000313	CcSEcCtD
Gabapentin—Constipation—Risedronate—osteoporosis	0.000274	0.000313	CcSEcCtD
Gabapentin—Shock—Zoledronate—osteoporosis	0.000274	0.000312	CcSEcCtD
Gabapentin—Paraesthesia—Pamidronate—osteoporosis	0.000274	0.000312	CcSEcCtD
Gabapentin—Diarrhoea—Alendronate—osteoporosis	0.000273	0.000312	CcSEcCtD
Gabapentin—Asthenia—Calcitriol—osteoporosis	0.000273	0.000312	CcSEcCtD
Gabapentin—Nervous system disorder—Zoledronate—osteoporosis	0.000273	0.000311	CcSEcCtD
Gabapentin—Immune system disorder—Estradiol—osteoporosis	0.000273	0.000311	CcSEcCtD
Gabapentin—Thrombocytopenia—Zoledronate—osteoporosis	0.000272	0.000311	CcSEcCtD
Gabapentin—Mediastinal disorder—Estradiol—osteoporosis	0.000272	0.00031	CcSEcCtD
Gabapentin—Dyspnoea—Pamidronate—osteoporosis	0.000272	0.00031	CcSEcCtD
Gabapentin—Tachycardia—Zoledronate—osteoporosis	0.000272	0.00031	CcSEcCtD
Gabapentin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000271	0.000309	CcSEcCtD
Gabapentin—Chills—Estradiol—osteoporosis	0.000271	0.000309	CcSEcCtD
Gabapentin—Somnolence—Pamidronate—osteoporosis	0.000271	0.000309	CcSEcCtD
Gabapentin—Skin disorder—Zoledronate—osteoporosis	0.00027	0.000308	CcSEcCtD
Gabapentin—Pruritus—Calcitriol—osteoporosis	0.000269	0.000307	CcSEcCtD
Gabapentin—Hyperhidrosis—Zoledronate—osteoporosis	0.000269	0.000307	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—P4HB—osteoporosis	0.000269	0.00267	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000269	0.000307	CcSEcCtD
Gabapentin—Diarrhoea—Raloxifene—osteoporosis	0.000269	0.000307	CcSEcCtD
Gabapentin—Dyspepsia—Pamidronate—osteoporosis	0.000268	0.000306	CcSEcCtD
Gabapentin—Dizziness—Estropipate—osteoporosis	0.000268	0.000306	CcSEcCtD
Gabapentin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000268	0.000306	CcSEcCtD
Gabapentin—Oedema—Conjugated Estrogens—osteoporosis	0.000268	0.000306	CcSEcCtD
Gabapentin—Alopecia—Estradiol—osteoporosis	0.000267	0.000304	CcSEcCtD
Gabapentin—Infection—Conjugated Estrogens—osteoporosis	0.000266	0.000304	CcSEcCtD
Gabapentin—Diarrhoea—Ibandronate—osteoporosis	0.000266	0.000304	CcSEcCtD
Gabapentin—Anorexia—Zoledronate—osteoporosis	0.000265	0.000303	CcSEcCtD
Gabapentin—Decreased appetite—Pamidronate—osteoporosis	0.000265	0.000302	CcSEcCtD
Gabapentin—Mental disorder—Estradiol—osteoporosis	0.000264	0.000302	CcSEcCtD
Gabapentin—Dizziness—Alendronate—osteoporosis	0.000264	0.000301	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GAPDH—osteoporosis	0.000264	0.00262	CbGpPWpGaD
Gabapentin—Shock—Conjugated Estrogens—osteoporosis	0.000264	0.000301	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000263	0.0003	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PTH—osteoporosis	0.000263	0.00261	CbGpPWpGaD
Gabapentin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000263	0.0003	CcSEcCtD
Gabapentin—Erythema—Estradiol—osteoporosis	0.000263	0.0003	CcSEcCtD
Gabapentin—Malnutrition—Estradiol—osteoporosis	0.000263	0.0003	CcSEcCtD
Gabapentin—Fatigue—Pamidronate—osteoporosis	0.000263	0.0003	CcSEcCtD
Gabapentin—Gastrointestinal pain—Risedronate—osteoporosis	0.000262	0.000299	CcSEcCtD
Gabapentin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000262	0.000298	CcSEcCtD
Gabapentin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000261	0.000298	CcSEcCtD
Gabapentin—Constipation—Pamidronate—osteoporosis	0.000261	0.000297	CcSEcCtD
Gabapentin—Pain—Pamidronate—osteoporosis	0.000261	0.000297	CcSEcCtD
Gabapentin—Diarrhoea—Calcitriol—osteoporosis	0.00026	0.000297	CcSEcCtD
Gabapentin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00026	0.000297	CcSEcCtD
Gabapentin—Hypotension—Zoledronate—osteoporosis	0.00026	0.000297	CcSEcCtD
Gabapentin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00026	0.000297	CcSEcCtD
Gabapentin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00026	0.000297	CcSEcCtD
Gabapentin—Dizziness—Raloxifene—osteoporosis	0.00026	0.000296	CcSEcCtD
Gabapentin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000259	0.000296	CcSEcCtD
Gabapentin—Flatulence—Estradiol—osteoporosis	0.000259	0.000295	CcSEcCtD
Gabapentin—Tension—Estradiol—osteoporosis	0.000258	0.000294	CcSEcCtD
Gabapentin—Vomiting—Estropipate—osteoporosis	0.000258	0.000294	CcSEcCtD
Gabapentin—Dysgeusia—Estradiol—osteoporosis	0.000257	0.000294	CcSEcCtD
Gabapentin—Dizziness—Ibandronate—osteoporosis	0.000257	0.000293	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—RAP1A—osteoporosis	0.000257	0.00256	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000257	0.00255	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR2—osteoporosis	0.000256	0.00255	CbGpPWpGaD
Gabapentin—Rash—Estropipate—osteoporosis	0.000256	0.000292	CcSEcCtD
Gabapentin—Dermatitis—Estropipate—osteoporosis	0.000255	0.000292	CcSEcCtD
Gabapentin—Anorexia—Conjugated Estrogens—osteoporosis	0.000255	0.000291	CcSEcCtD
Gabapentin—Nervousness—Estradiol—osteoporosis	0.000255	0.000291	CcSEcCtD
Gabapentin—Urticaria—Risedronate—osteoporosis	0.000255	0.000291	CcSEcCtD
Gabapentin—Back pain—Estradiol—osteoporosis	0.000254	0.00029	CcSEcCtD
Gabapentin—Headache—Estropipate—osteoporosis	0.000254	0.00029	CcSEcCtD
Gabapentin—Vomiting—Alendronate—osteoporosis	0.000254	0.00029	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000254	0.000289	CcSEcCtD
Gabapentin—Abdominal pain—Risedronate—osteoporosis	0.000253	0.000289	CcSEcCtD
Gabapentin—Body temperature increased—Risedronate—osteoporosis	0.000253	0.000289	CcSEcCtD
Gabapentin—Muscle spasms—Estradiol—osteoporosis	0.000253	0.000288	CcSEcCtD
Gabapentin—Rash—Alendronate—osteoporosis	0.000252	0.000287	CcSEcCtD
Gabapentin—Insomnia—Zoledronate—osteoporosis	0.000252	0.000287	CcSEcCtD
Gabapentin—Dermatitis—Alendronate—osteoporosis	0.000252	0.000287	CcSEcCtD
Gabapentin—Feeling abnormal—Pamidronate—osteoporosis	0.000251	0.000286	CcSEcCtD
Gabapentin—Hypotension—Conjugated Estrogens—osteoporosis	0.00025	0.000286	CcSEcCtD
Gabapentin—Headache—Alendronate—osteoporosis	0.00025	0.000286	CcSEcCtD
Gabapentin—Paraesthesia—Zoledronate—osteoporosis	0.00025	0.000285	CcSEcCtD
Gabapentin—Vomiting—Raloxifene—osteoporosis	0.00025	0.000285	CcSEcCtD
Gabapentin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000249	0.000284	CcSEcCtD
Gabapentin—Dyspnoea—Zoledronate—osteoporosis	0.000248	0.000283	CcSEcCtD
Gabapentin—Rash—Raloxifene—osteoporosis	0.000248	0.000283	CcSEcCtD
Gabapentin—Dermatitis—Raloxifene—osteoporosis	0.000247	0.000282	CcSEcCtD
Gabapentin—Somnolence—Zoledronate—osteoporosis	0.000247	0.000282	CcSEcCtD
Gabapentin—Vomiting—Ibandronate—osteoporosis	0.000247	0.000282	CcSEcCtD
Gabapentin—Tremor—Estradiol—osteoporosis	0.000246	0.000281	CcSEcCtD
Gabapentin—Headache—Raloxifene—osteoporosis	0.000246	0.000281	CcSEcCtD
Gabapentin—Rash—Ibandronate—osteoporosis	0.000245	0.00028	CcSEcCtD
Gabapentin—Dermatitis—Ibandronate—osteoporosis	0.000245	0.00028	CcSEcCtD
Gabapentin—Dyspepsia—Zoledronate—osteoporosis	0.000245	0.00028	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000244	0.000279	CcSEcCtD
Gabapentin—Ill-defined disorder—Estradiol—osteoporosis	0.000244	0.000278	CcSEcCtD
Gabapentin—Headache—Ibandronate—osteoporosis	0.000244	0.000278	CcSEcCtD
Gabapentin—Insomnia—Conjugated Estrogens—osteoporosis	0.000242	0.000277	CcSEcCtD
Gabapentin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000242	0.000276	CcSEcCtD
Gabapentin—Vomiting—Calcitriol—osteoporosis	0.000242	0.000276	CcSEcCtD
Gabapentin—Decreased appetite—Zoledronate—osteoporosis	0.000242	0.000276	CcSEcCtD
Gabapentin—Agitation—Estradiol—osteoporosis	0.000241	0.000276	CcSEcCtD
Gabapentin—Nausea—Estropipate—osteoporosis	0.000241	0.000275	CcSEcCtD
Gabapentin—Abdominal pain—Pamidronate—osteoporosis	0.000241	0.000275	CcSEcCtD
Gabapentin—Body temperature increased—Pamidronate—osteoporosis	0.000241	0.000275	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—WNT1—osteoporosis	0.000241	0.00239	CbGpPWpGaD
Gabapentin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000241	0.000275	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00024	0.000274	CcSEcCtD
Gabapentin—Angioedema—Estradiol—osteoporosis	0.00024	0.000274	CcSEcCtD
Gabapentin—Rash—Calcitriol—osteoporosis	0.00024	0.000274	CcSEcCtD
Gabapentin—Fatigue—Zoledronate—osteoporosis	0.00024	0.000274	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—osteoporosis	0.00024	0.00238	CbGpPWpGaD
Gabapentin—Dermatitis—Calcitriol—osteoporosis	0.00024	0.000274	CcSEcCtD
Gabapentin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000239	0.000273	CcSEcCtD
Gabapentin—Headache—Calcitriol—osteoporosis	0.000238	0.000272	CcSEcCtD
Gabapentin—Somnolence—Conjugated Estrogens—osteoporosis	0.000238	0.000272	CcSEcCtD
Gabapentin—Constipation—Zoledronate—osteoporosis	0.000238	0.000272	CcSEcCtD
Gabapentin—Pain—Zoledronate—osteoporosis	0.000238	0.000272	CcSEcCtD
Gabapentin—Nausea—Alendronate—osteoporosis	0.000237	0.000271	CcSEcCtD
Gabapentin—Malaise—Estradiol—osteoporosis	0.000237	0.00027	CcSEcCtD
Gabapentin—Hypersensitivity—Risedronate—osteoporosis	0.000236	0.000269	CcSEcCtD
Gabapentin—Vertigo—Estradiol—osteoporosis	0.000236	0.000269	CcSEcCtD
Gabapentin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000236	0.000269	CcSEcCtD
Gabapentin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000236	0.000269	CcSEcCtD
Gabapentin—Syncope—Estradiol—osteoporosis	0.000236	0.000269	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MGLL—osteoporosis	0.000235	0.00233	CbGpPWpGaD
Gabapentin—Nausea—Raloxifene—osteoporosis	0.000233	0.000266	CcSEcCtD
Gabapentin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000233	0.000266	CcSEcCtD
Gabapentin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000233	0.000265	CcSEcCtD
Gabapentin—Palpitations—Estradiol—osteoporosis	0.000232	0.000265	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000231	0.000264	CcSEcCtD
Gabapentin—Fatigue—Conjugated Estrogens—osteoporosis	0.000231	0.000264	CcSEcCtD
Gabapentin—Nausea—Ibandronate—osteoporosis	0.000231	0.000264	CcSEcCtD
Gabapentin—Loss of consciousness—Estradiol—osteoporosis	0.000231	0.000264	CcSEcCtD
Gabapentin—Asthenia—Risedronate—osteoporosis	0.00023	0.000262	CcSEcCtD
Gabapentin—Feeling abnormal—Zoledronate—osteoporosis	0.000229	0.000262	CcSEcCtD
Gabapentin—Cough—Estradiol—osteoporosis	0.000229	0.000262	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LRP5—osteoporosis	0.000229	0.00228	CbGpPWpGaD
Gabapentin—Pain—Conjugated Estrogens—osteoporosis	0.000229	0.000261	CcSEcCtD
Gabapentin—Constipation—Conjugated Estrogens—osteoporosis	0.000229	0.000261	CcSEcCtD
Gabapentin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000228	0.00026	CcSEcCtD
Gabapentin—Hypertension—Estradiol—osteoporosis	0.000227	0.000259	CcSEcCtD
Gabapentin—Pruritus—Risedronate—osteoporosis	0.000227	0.000259	CcSEcCtD
Gabapentin—Nausea—Calcitriol—osteoporosis	0.000226	0.000258	CcSEcCtD
Gabapentin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000225	0.000257	CcSEcCtD
Gabapentin—Hypersensitivity—Pamidronate—osteoporosis	0.000224	0.000256	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ADCY5—osteoporosis	0.000224	0.00223	CbGpPWpGaD
Gabapentin—Chest pain—Estradiol—osteoporosis	0.000224	0.000255	CcSEcCtD
Gabapentin—Arthralgia—Estradiol—osteoporosis	0.000224	0.000255	CcSEcCtD
Gabapentin—Myalgia—Estradiol—osteoporosis	0.000224	0.000255	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GPX1—osteoporosis	0.000223	0.00222	CbGpPWpGaD
Gabapentin—Anxiety—Estradiol—osteoporosis	0.000223	0.000254	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000222	0.000254	CcSEcCtD
Gabapentin—Urticaria—Zoledronate—osteoporosis	0.000221	0.000252	CcSEcCtD
Gabapentin—Discomfort—Estradiol—osteoporosis	0.000221	0.000252	CcSEcCtD
Gabapentin—Abdominal pain—Zoledronate—osteoporosis	0.00022	0.000251	CcSEcCtD
Gabapentin—Body temperature increased—Zoledronate—osteoporosis	0.00022	0.000251	CcSEcCtD
Gabapentin—Diarrhoea—Risedronate—osteoporosis	0.000219	0.00025	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LRP6—osteoporosis	0.000219	0.00218	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000219	0.00025	CcSEcCtD
Gabapentin—Dry mouth—Estradiol—osteoporosis	0.000219	0.00025	CcSEcCtD
Gabapentin—Asthenia—Pamidronate—osteoporosis	0.000219	0.000249	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—osteoporosis	0.000218	0.00216	CbGpPWpGaD
Gabapentin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000217	0.000248	CcSEcCtD
Gabapentin—Confusional state—Estradiol—osteoporosis	0.000216	0.000247	CcSEcCtD
Gabapentin—Pruritus—Pamidronate—osteoporosis	0.000216	0.000246	CcSEcCtD
Gabapentin—Anaphylactic shock—Estradiol—osteoporosis	0.000214	0.000245	CcSEcCtD
Gabapentin—Oedema—Estradiol—osteoporosis	0.000214	0.000245	CcSEcCtD
Gabapentin—Infection—Estradiol—osteoporosis	0.000213	0.000243	CcSEcCtD
Gabapentin—Urticaria—Conjugated Estrogens—osteoporosis	0.000213	0.000243	CcSEcCtD
Gabapentin—Dizziness—Risedronate—osteoporosis	0.000212	0.000242	CcSEcCtD
Gabapentin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000212	0.000242	CcSEcCtD
Gabapentin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000212	0.000242	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CALCA—osteoporosis	0.000211	0.0021	CbGpPWpGaD
Gabapentin—Shock—Estradiol—osteoporosis	0.000211	0.000241	CcSEcCtD
Gabapentin—Nervous system disorder—Estradiol—osteoporosis	0.00021	0.00024	CcSEcCtD
Gabapentin—Tachycardia—Estradiol—osteoporosis	0.000209	0.000239	CcSEcCtD
Gabapentin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000209	0.000238	CcSEcCtD
Gabapentin—Diarrhoea—Pamidronate—osteoporosis	0.000208	0.000238	CcSEcCtD
Gabapentin—Skin disorder—Estradiol—osteoporosis	0.000208	0.000238	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ENO1—osteoporosis	0.000208	0.00207	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Estradiol—osteoporosis	0.000207	0.000237	CcSEcCtD
Gabapentin—Rash—Ethinyl Estradiol—osteoporosis	0.000207	0.000237	CcSEcCtD
Gabapentin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000207	0.000236	CcSEcCtD
Gabapentin—BCAT1—Metabolism—MTHFR—osteoporosis	0.000206	0.00205	CbGpPWpGaD
Gabapentin—Headache—Ethinyl Estradiol—osteoporosis	0.000206	0.000235	CcSEcCtD
Gabapentin—Hypersensitivity—Zoledronate—osteoporosis	0.000205	0.000234	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PSMA2—osteoporosis	0.000205	0.00204	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSMA5—osteoporosis	0.000205	0.00204	CbGpPWpGaD
Gabapentin—Vomiting—Risedronate—osteoporosis	0.000204	0.000233	CcSEcCtD
Gabapentin—Rash—Risedronate—osteoporosis	0.000202	0.000231	CcSEcCtD
Gabapentin—Dermatitis—Risedronate—osteoporosis	0.000202	0.00023	CcSEcCtD
Gabapentin—Dizziness—Pamidronate—osteoporosis	0.000201	0.00023	CcSEcCtD
Gabapentin—Headache—Risedronate—osteoporosis	0.000201	0.000229	CcSEcCtD
Gabapentin—Asthenia—Zoledronate—osteoporosis	0.0002	0.000228	CcSEcCtD
Gabapentin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000197	0.000225	CcSEcCtD
Gabapentin—Pruritus—Zoledronate—osteoporosis	0.000197	0.000225	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—POMC—osteoporosis	0.000195	0.00194	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000195	0.000223	CcSEcCtD
Gabapentin—Nausea—Ethinyl Estradiol—osteoporosis	0.000195	0.000223	CcSEcCtD
Gabapentin—Insomnia—Estradiol—osteoporosis	0.000194	0.000221	CcSEcCtD
Gabapentin—Vomiting—Pamidronate—osteoporosis	0.000194	0.000221	CcSEcCtD
Gabapentin—Paraesthesia—Estradiol—osteoporosis	0.000193	0.00022	CcSEcCtD
Gabapentin—Asthenia—Conjugated Estrogens—osteoporosis	0.000192	0.000219	CcSEcCtD
Gabapentin—Rash—Pamidronate—osteoporosis	0.000192	0.000219	CcSEcCtD
Gabapentin—Dermatitis—Pamidronate—osteoporosis	0.000192	0.000219	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CALCA—osteoporosis	0.000192	0.00191	CbGpPWpGaD
Gabapentin—Dyspnoea—Estradiol—osteoporosis	0.000191	0.000218	CcSEcCtD
Gabapentin—Headache—Pamidronate—osteoporosis	0.000191	0.000218	CcSEcCtD
Gabapentin—Somnolence—Estradiol—osteoporosis	0.000191	0.000218	CcSEcCtD
Gabapentin—Diarrhoea—Zoledronate—osteoporosis	0.00019	0.000217	CcSEcCtD
Gabapentin—Nausea—Risedronate—osteoporosis	0.00019	0.000217	CcSEcCtD
Gabapentin—Pruritus—Conjugated Estrogens—osteoporosis	0.00019	0.000216	CcSEcCtD
Gabapentin—Dyspepsia—Estradiol—osteoporosis	0.000189	0.000215	CcSEcCtD
Gabapentin—Decreased appetite—Estradiol—osteoporosis	0.000186	0.000213	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000185	0.000211	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TLN1—osteoporosis	0.000185	0.00184	CbGpPWpGaD
Gabapentin—Fatigue—Estradiol—osteoporosis	0.000185	0.000211	CcSEcCtD
Gabapentin—Dizziness—Zoledronate—osteoporosis	0.000184	0.00021	CcSEcCtD
Gabapentin—Constipation—Estradiol—osteoporosis	0.000183	0.000209	CcSEcCtD
Gabapentin—Pain—Estradiol—osteoporosis	0.000183	0.000209	CcSEcCtD
Gabapentin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000183	0.000209	CcSEcCtD
Gabapentin—Nausea—Pamidronate—osteoporosis	0.000181	0.000207	CcSEcCtD
Gabapentin—Dizziness—Conjugated Estrogens—osteoporosis	0.000177	0.000202	CcSEcCtD
Gabapentin—Vomiting—Zoledronate—osteoporosis	0.000177	0.000202	CcSEcCtD
Gabapentin—Feeling abnormal—Estradiol—osteoporosis	0.000177	0.000202	CcSEcCtD
Gabapentin—Rash—Zoledronate—osteoporosis	0.000175	0.0002	CcSEcCtD
Gabapentin—Gastrointestinal pain—Estradiol—osteoporosis	0.000175	0.0002	CcSEcCtD
Gabapentin—Dermatitis—Zoledronate—osteoporosis	0.000175	0.0002	CcSEcCtD
Gabapentin—Headache—Zoledronate—osteoporosis	0.000174	0.000199	CcSEcCtD
Gabapentin—Vomiting—Conjugated Estrogens—osteoporosis	0.00017	0.000194	CcSEcCtD
Gabapentin—Urticaria—Estradiol—osteoporosis	0.00017	0.000194	CcSEcCtD
Gabapentin—Abdominal pain—Estradiol—osteoporosis	0.00017	0.000193	CcSEcCtD
Gabapentin—Body temperature increased—Estradiol—osteoporosis	0.00017	0.000193	CcSEcCtD
Gabapentin—Rash—Conjugated Estrogens—osteoporosis	0.000169	0.000193	CcSEcCtD
Gabapentin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000169	0.000193	CcSEcCtD
Gabapentin—Headache—Conjugated Estrogens—osteoporosis	0.000168	0.000192	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP19A1—osteoporosis	0.000166	0.00165	CbGpPWpGaD
Gabapentin—Nausea—Zoledronate—osteoporosis	0.000165	0.000189	CcSEcCtD
Gabapentin—BCAT1—Metabolism—POMC—osteoporosis	0.000165	0.00164	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—P4HB—osteoporosis	0.00016	0.00159	CbGpPWpGaD
Gabapentin—Nausea—Conjugated Estrogens—osteoporosis	0.000159	0.000182	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—osteoporosis	0.000159	0.00158	CbGpPWpGaD
Gabapentin—Hypersensitivity—Estradiol—osteoporosis	0.000158	0.00018	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PTH—osteoporosis	0.000155	0.00154	CbGpPWpGaD
Gabapentin—Asthenia—Estradiol—osteoporosis	0.000154	0.000176	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—RAP1A—osteoporosis	0.000153	0.00152	CbGpPWpGaD
Gabapentin—Pruritus—Estradiol—osteoporosis	0.000152	0.000173	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CNR2—osteoporosis	0.000151	0.0015	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADCY5—osteoporosis	0.00015	0.00149	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFATC1—osteoporosis	0.000149	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DKK1—osteoporosis	0.000148	0.00147	CbGpPWpGaD
Gabapentin—Diarrhoea—Estradiol—osteoporosis	0.000147	0.000167	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—WNT1—osteoporosis	0.000142	0.00141	CbGpPWpGaD
Gabapentin—Dizziness—Estradiol—osteoporosis	0.000142	0.000162	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGA—osteoporosis	0.000138	0.00138	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADCY5—osteoporosis	0.000136	0.00136	CbGpPWpGaD
Gabapentin—Vomiting—Estradiol—osteoporosis	0.000136	0.000156	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ADCY5—osteoporosis	0.000136	0.00135	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—osteoporosis	0.000135	0.00135	CbGpPWpGaD
Gabapentin—Rash—Estradiol—osteoporosis	0.000135	0.000154	CcSEcCtD
Gabapentin—Dermatitis—Estradiol—osteoporosis	0.000135	0.000154	CcSEcCtD
Gabapentin—Headache—Estradiol—osteoporosis	0.000134	0.000153	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—osteoporosis	0.000129	0.00128	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BMP2—osteoporosis	0.000129	0.00128	CbGpPWpGaD
Gabapentin—Nausea—Estradiol—osteoporosis	0.000127	0.000145	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGB—osteoporosis	0.000126	0.00125	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—osteoporosis	0.000125	0.00124	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMA2—osteoporosis	0.000122	0.00121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMA5—osteoporosis	0.000122	0.00121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALCA—osteoporosis	0.000113	0.00113	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—osteoporosis	0.00011	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KL—osteoporosis	0.000103	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—POMC—osteoporosis	0.0001	0.000997	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—osteoporosis	9.99e-05	0.000993	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6R—osteoporosis	9.78e-05	0.000973	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADCY5—osteoporosis	8.06e-05	0.000801	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—osteoporosis	7.79e-05	0.000775	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS2—osteoporosis	7.05e-05	0.000701	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—osteoporosis	6.9e-05	0.000686	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—osteoporosis	6.59e-05	0.000655	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—osteoporosis	6.15e-05	0.000612	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—osteoporosis	5.93e-05	0.000589	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6R—osteoporosis	5.78e-05	0.000575	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—osteoporosis	5.7e-05	0.000567	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—osteoporosis	4.36e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—osteoporosis	3.43e-05	0.000341	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—osteoporosis	3.42e-05	0.00034	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—osteoporosis	2.57e-05	0.000256	CbGpPWpGaD
